Cloning of a c-myc gene rearranged at the 3′ derived from a human leukemic T cell line*
Deborah F. Aghib(University of Milan), Giuseppe Saglio(University of Turin), Paola Comi(University of Milan), M. C. Giubellino, Angelo Guerrasio, Barbára Giglioni, Anna Serra(University of Turin), Sergio Ottolenghi(University of Milano-Bicocca)
Cited by 0
Related Papers
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
|Leukemia|2012|440
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
|Journal of Clinical Oncology|2009|434
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
|Blood|2013|391
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
|Blood|2001|319
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
|Leukemia|2018|250